ADRENERGIC MECHANISMS AND AMPHETAMINE INDUCED ABNORMAL BEHAVIOUR.
D018663:Adrenergic Agents; D000661:Amphetamine; D000662:Amphetamines; D001522:Behavior, Animal; D002746:Chlorpromazine; D003913:Dextroamphetamine; D004088:Dihydroergotoxine; D004876:Ergot Alkaloids; D004878:Ergotamine; D006220:Haloperidol; D007545:Isoproterenol / Q000031:analogs & derivatives; D010600:Pharmacology; D010643:Phenoxybenzamine; D010646:Phentolamine; D051381:Rats; D012106:Research; D012110:Reserpine; D013565:Sympatholytics
D018663:Adrenergic Agents; D000662:Amphetamines; D004876:Ergot Alkaloids; D013565:Sympatholytics; D010643:Phenoxybenzamine; D004088:Dihydroergotoxine; D012110:Reserpine; D000661:Amphetamine; D006220:Haloperidol; D007545:Isoproterenol; D004878:Ergotamine; D003913:Dextroamphetamine; D002746:Chlorpromazine; C084581:dichloroisoproterenol; D010646:Phentolamine
BEHAVIOR, ANIMAL; CHLORPROMAZINE; DEXTRO AMPHETAMINE; DICHLOROISOPROTERENOL; ERGOT ALKALOIDS, HYDROGENATED; ERGOTAMINE; EXPERIMENTAL LAB STUDY; HALOPERIDOL; PHARMACOLOGY; PHENOXYBENZAMINE; PHENTOLAMINE; RATS; RESERPINE; SYMPATHOLYTICS